These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8135497)

  • 1. C-peptide pattern in patients with pancreatic cancer.
    Fogar P; Basso D; Panozzo MP; Del Favero G; Briani G; Fabris C; D'Angeli F; Meggiato T; Ferrara C; Plebani M
    Anticancer Res; 1993; 13(6B):2577-80. PubMed ID: 8135497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus in pancreatic cancer follow-up.
    Fogar P; Pasquali C; Basso D; Sperti C; Panozzo MP; Tessari G; D'Angeli F; Del Favero G; Plebani M
    Anticancer Res; 1994; 14(6B):2827-30. PubMed ID: 7532931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
    Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
    Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
    Nakamori S; Ishikawa O; Ohigashi H; Sasakuma F; Shimizu T; Nakaizumi A; Furukawa H; Sasaki Y; Imaoka S
    Hepatogastroenterology; 1999; 46(25):16-24. PubMed ID: 10228759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
    Kan Y; Chi Z
    Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of pancreatin on diabetes mellitus in chronic pancreatitis].
    Glasbrenner B; Malfertheiner P; Kerner W; Scherbaum WA; Ditschuneit H
    Z Gastroenterol; 1990 Jun; 28(6):275-9. PubMed ID: 2238755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose resistance contributes to diabetes mellitus in cirrhosis.
    Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
    Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of ketoacidosis in Type 2 diabetes mellitus.
    Linfoot P; Bergstrom C; Ipp E
    Diabet Med; 2005 Oct; 22(10):1414-9. PubMed ID: 16176205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different endocrine stimulation tests in nondiabetic patients with chronic pancreatitis.
    von Tirpitz C; Glasbrenner B; Mayer D; Malfertheiner P; Adler G
    Hepatogastroenterology; 1998; 45(22):1111-6. PubMed ID: 9756016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus secondary to chronic pancreatitis.
    Larsen S
    Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of immunoreactive serum levels of insulin, C peptide and glucagon in patients with acute pancreatitis and acute abdominal pain of non-pancreatic origin (author's transl)].
    Roca Martínez FJ; Rubio Rubio JM; Martín Gómez R; Zamora Madaria E
    Med Clin (Barc); 1982 Jan; 78(1):13-6. PubMed ID: 7038321
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
    Knop FK; Vilsbøll T; Højberg PV; Larsen S; Madsbad S; Holst JJ; Krarup T
    Regul Pept; 2007 Dec; 144(1-3):123-30. PubMed ID: 17692937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRH-immunoreactivity in chronic pancreatitis.
    Duntas L; Glasbrenner B; Wolf C; Pieramico O; Büchler M; Malfertheiner P
    Hepatogastroenterology; 1992 Oct; 39(5):413-6. PubMed ID: 1459520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C reactive protein in pancreatic cancer and chronic pancreatitis.
    Basso D; Fabris C; Meani A; Del Favero G; Vianello D; Angonese C; Meggiato T; Bellinvia S; Fogar P; Petrin P
    Ann Clin Res; 1988; 20(6):414-6. PubMed ID: 3218913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.